CK Life Sciences Reports Promising Preclinical Results for TROP2-Targeted Cancer Vaccine
China-based CK Life Sciences (HKG: 0775) has announced positive early results from preclinical studies of...
HKG: 0775
CK Life Sciences’ Halneuron Receives FDA Fast-Track Designation for Chemotherapy-Induced Neuropathic Pain
CK Life Sciences (HKG: 0775), a biopharmaceutical company headquartered in China, has received fast-track designation...
XtalPi Inc. and CK Life Sciences Expand Partnership to Develop AI-Powered Cancer Diagnostics
Sino-US artificial intelligence (AI) firm XtalPi (QuantumPharm, HKG: 2228) has announced a strategic partnership agreement...